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External beam radiotherapyIn recent years, accelerated partial breast irradiation (APBI) has been considered an alternative to whole
breast irradiation for patients undergoing breast-conserving therapy. APBI delivers higher doses of radi-
ation in fewer fractions to the post-lumpectomy tumor bed with a 1–2 cm margin, targeting the area at
the highest risk of local recurrence while sparing normal breast tissue. However, there are inherent chal-
lenges in deﬁning accurate target volumes for APBI. Studies have shown that signiﬁcant interobserver
variation exists among radiation oncologists deﬁning the lumpectomy cavity, which raises the question
of how to improve the accuracy and consistency in the delineation of tumor bed volumes. The combina-
tion of standardized guidelines and surgical clips signiﬁcantly improves an observer’s ability in delinea-
tion, and it is the standard in multiple ongoing external-beam APBI trials. However, questions about the
accuracy of the clips to mark the lumpectomy cavity remain, as clips only deﬁne a few points at the mar-
gin of the cavity. This paper reviews the techniques that have been developed so far to improve target
delineation in APBI delivered by conformal external beam radiation therapy, including the use of stan-
dardized guidelines, surgical clips or ﬁducial markers, pre-operative computed tomography imaging,
and additional imaging modalities, including magnetic resonance imaging, ultrasound imaging, and pos-
itron emission tomography/computed tomography. Alternatives to post-operative APBI, future directions,
and clinical recommendations were also discussed.
 2013 The Authors. Published by Elsevier Ireland Ltd. Radiotherapy and Oncology 108 (2013) 181–189
Open access under CC BY-NC-ND license. Breast-conserving therapy (BCT) consists of wide local excision
followed by radiation therapy (RT) to the whole breast. The efﬁcacy
of BCT in the treatment of early-stage breast cancer has been estab-
lished through multiple randomized trials [1–6]. Three of the larg-
est trials with twenty-year follow-up demonstrated equivalent
survival between patients who received BCT compared to mastec-
tomy [3–5]. The addition of boost irradiation to the tumor bed after
whole breast irradiation has been shown to further improve local
control [7]. As radiation morbidity is directly related to irradiated
volume [8], limiting RT treatment volume can expectedly decrease
late toxicity. Accelerated partial breast irradiation (APBI) delivers a
whole course of post-operative RT to the lumpectomy tumor bed,
whereas conventional RT after BCT is delivered to the whole breast
with a few more fractions of the radiation given to the tumor bed
as a boost. APBI has gained popularity in recent years. Its ability to
limit RT exposure to normal tissues and its shorter treatmentcourse are some of the reasons that make it attractive for both cli-
nicians and patients with early-stage breast cancer suitable for
APBI treatment. The rationale for this strategy is that most local
recurrences appear close to the tumorectomy cavity [9]. Pathologic
studies have also shown that tumor cells rarely extend 4 cm
beyond the index lesion [10]. These studies suggest that RT offers
the greatest local control beneﬁt when doses are directed to the
tumor bed.
There are multiple delivery methods for APBI [9,11–13] and
external beam RT (EBRT) is a popular technique utilized due to
its non-invasive nature and availability. In small series, external
beam APBI (EB APBI) has shown adequate efﬁcacy and limited tox-
icity at short-term follow-up [11,14]. A larger planning target vol-
ume (PTV) is also used in EB APBI. The clinical target volume (CTV)
is derived from adding a margin of usually 1.5 cm around the
tumor bed volume (TBV). Then, an additional 0.5–1.0 cm margin
is added to obtain the PTV. For interstitial brachytherapy APBI,
however, no additional margin around the CTV is required; there-
fore the CTV is the PTV. Depending on the technique used, the
182 Variability in breast tumor-bed delineationcoverage of the PTV and thereby the irradiated volume varies con-
siderably. The irradiated volume in IORT is in general small, with
the dose mainly delivered to the surface of the surgical tumor
bed, which then attenuates to deliver lower doses to the surround-
ing tissue. As the tumor is often eccentric in the lumpectomy spec-
imen, treatments given at the time of surgery can lead to
insufﬁcient dose delivery to the high-risk region (Fig. 1) [15]. This
is typically not the case for APBI delivered with EB or with intersti-
tial brachytherapy, as with these techniques conformal RT can be
delivered to the entire high-risk region.
Given that APBI delivers conformal RT to the tumor bed with a
small margin, deﬁning the post-surgical tumor bed accurately for
treatment planning and delivery is essential in achieving treatment
efﬁcacy. However, several studies have shown that interobserver
variation is common among radiation oncologists in deﬁning the
lumpectomy cavity [15–17]. This review sets its scope to EB APBI
only. We will discuss four general methods investigated to
improve consistency in tumor bed deﬁnition during EB APBI plan-
ning, including the use of standardized guidelines, surgical clips or
ﬁducial markers, pre-operative computed tomography (CT) scans,
and additional imaging modalities in treatment planning, includ-
ing magnetic resonance imaging (MRI) and ultrasound (US) imag-
ing. We will also discuss recent reports of bypassing the
uncertainty of tumor bed delineation by applying EB APBI to the
intact tumor prior to lumpectomy, and future directions and clin-
ical recommendations.
While we present a comprehensive overview of the current
state of tumor bed delineation for APBI with this manuscript, a sys-
tematic review was performed speciﬁcally for the section in evalu-
ating methods in improving interobserver variability. We searched
for English-language papers published from January 2005 to May
2012. Studies comparing clinical methods in the evaluation of
interobserver variation in tumor bed delineation including guide-
lines, ﬁducial, and imaging were included. Using PubMed, the
search was completed in May 2012. The search strategy was (tar-
get[tw] or volume[tw] or tumor bed[tw]) AND breast[tw] AND
radiotherapy[tw] (delineation[tw] or contour[tw]), which identi-
ﬁed 74 studies. While many of the studies supported the theme
of improving tumor bed delineation with clinical tools, 14
described interobserver variations, and 8 provided a direct com-
parison of interobserver variation with and without the proposed
clinical strategy. These 8 studies were detailed in this manuscript.
Variability in tumor bed delineation
Accurate delineation of the target volume is a prerequisite of
conformal RT and is critical to achieving long-term local controlFig. 1. From Bartelink et al. [46]. Illustrations of breast tumors are often eccentric,
which may lead to variation in resection margins addressed by brachytherapy or
intraoperative radiotherapy (IORT). CTV = clinical target volume, PBI = partial breast
irradiation.for APBI. However, multiple studies have reported signiﬁcant inter-
observer variation in delineating post-lumpectomy cavities, indi-
cating observers’ inability to accurately and consistently deﬁne
treatment target volumes. It is important to note that many of
the studies to date looked at variability in tumor bed contours
for boost irradiation and are being used as a surrogate for APBI
tumor bed deﬁnition in this review. To quantify interobserver dis-
crepancies, in addition to volumetric analysis, investigators com-
monly use the following parameters in their studies (Fig. 2):
(1) Conformity index (CI): the ratio of the overlapping volume
and the encompassing total delineated volume of the structure of
interest, ranging from 0 to 1, with 0 indicating no overlap in vol-
ume and 1 implying perfect agreement. When evaluating smaller
volumes, such as TBV, a low CI is less relevant in indicating incon-
sistency, compared to a low CI when evaluating larger volumes,
such as CTV and PTV.
(2) Center of mass displacement (COMd): the variation in dis-
tance between the centers of two delineated structures. A zero
COMd signiﬁes that the delineations are centered at the same posi-
tion but does not mean the structures are the same.
(3) Standard deviation (SD): the standard deviation of the vari-
ations in distances among observers’ delineations. This value
describes the distribution of interobserver variation around the
mean.
Table 1 shows a comparison of studies demonstrating poor
interobserver consistencies in tumor bed delineation. Struikmans
et al. compared the CI of target volumes for boost irradiation using
eighteen patients’ treatment planning CT scans [18]. The authors
found high interobserver variability (CI = 0.56), which was
enhanced by the relatively small boost volume. Similar ﬁndings
were demonstrated by Landis et al., reporting a mean overlap of
57% for the contoured lumpectomy cavity and a median COMd of
0.69 cm between four radiation oncologists in patients with low
post-surgical cavity clarity [15]. These clarity and volume effects
on observer discrepancies were echoed by investigators at the Brit-
ish Columbia Cancer Agency and the Netherlands Cancer Institute
[16,19]. To evaluate multi-institutional and multi-observer vari-
ability, Li et al. compared the contoured target volumes of nine
radiation oncologists from eight institutions. Despite the clearly
visible seroma and surgical clips in the two patients in the study,
the authors found that the delineated size (cm3) of the lumpec-
tomy cavity varied by an average of 36% and the mean COMd
was 0.23 cm [20]. From the above studies, we ﬁnd that there are
clinically relevant differences between observers in lumpectomy
cavity delineation. Discrepancies in contouring target structures
can undermine the precision of conformal RT. In order to ensure
adequate RT delivery through APBI to areas at risk, it is crucial to
establish consistency in target volume delineation. Furthermore,
as the long-term effectiveness of APBI is still being evaluated
through multiple clinical trials [21–24], discrepancies in target vol-
ume deﬁnitions by different investigators may negatively inﬂuence
trial results.Lumpectomy cavity closure
Before examining clinical strategies in improving variability in
target delineation for EB APBI, it is important to brieﬂy discuss
the how surgical techniques may inﬂuence an observer’s ability
in contouring the post-surgical cavity and its implication. During
a lumpectomy, surgeons traditionally elect to use either a superﬁ-
cial or full-thickness closure when sealing the cavity. With super-
ﬁcial closure, only the superﬁcial aspect of the cavity is closed,
allowing the formation of a seroma to prevent deformation of
Fig. 2. From Petersen et al. [16]. (a) Illustration of the conformity index (CI) deﬁned as a ratio of overlapping volume to encompassing delineated volume: representations of
0%, 50%, and 100% concordance. (b) Case demonstrating variation in seroma contouring by three observers. CI = conformity index.
Table 1
Studies demonstrating poor interobserver consistencies in tumor bed delineation.
Publications Target volumes Number
of
patients
Observers Conformity
index (CI)
Center of mass
displacement
(COMd)
Factors reducing consistency
Struikmans
et al.
[18]
Boost target volume,
breast
18 5 (2 radiation
oncologists, 2
registrars, 1
radiologist)
CI boost:
0.56; CI
breast: 0.87
– Smaller target volume
Landis et al.
[15]
Lumpectomy cavity 33 4 (radiation
oncologists)
0.57 0.69 cm Smaller lumpectomy volume
Petersen
et al.
[16]
Seroma volume 30 3 (radiation
oncologists)
0.61 – Smaller seroma volume, low clarity score, tissue
stranding, proximity to the pectoralis, dense breast
tissue, benign calciﬁcations
Yang et al.
[19]
Seroma volume 19 2 (trainees, checked
by a radiation
oncologist)
0.61 – Smaller seroma volume, low clarity score
Li et al. [20] Lumpectomy cavity, boost,
breast, nodal volumes, and
chest wall
3 9 (radiation
oncologists from 8
institutions)
As low as
0.10
0.23 cm –
T.J. Yang et al. / Radiotherapy and Oncology 108 (2013) 181–189 183the breast. A full-thickness closure consists of repositioning of the
surrounding breast tissue and suturing the deep and superﬁcial
layers, preventing the development of signiﬁcant seroma [25,26].
There is a paucity of data on the inﬂuence of surgical closure
techniques on EB APBI treatment planning. It can be hypothesized
that superﬁcial closure may lead to a better-delineated cavity as a
well-visualized seroma has been shown to decrease interobserver
variations [19,27], nevertheless, it may also lead to a larger treat-
ment volume and greater late toxicity effects. However, with
full-thickness closure, the surgical clips may be displaced with
the approximation of the surrounding breast tissue and not correlate
with the true extend of the cavity. In a recently published single
institutional experience, Shaikh et al. did not ﬁnd statistically signif-
icant difference in mean cavity visualization scoring (CVS) (Smitt
et al., 1 = no visible cavity, 2–4 = heterogeneous cavity with indis-
tinct, distinct, or clearly deﬁned margins, 5 = homogenous cavity
with clearly deﬁned margins [28]) or normal tissue dosimetric end-
points between 29 patients who underwent superﬁcial closure and
sixteen patients who underwent full-thickness closure [29]. A higherpercentage of patients who underwent superﬁcial closure had CVS
scores >2 (79% vs. 63%). The small patient numbers in each cohort
and its retrospective nature are the limitations of the study.
Another important trend to consider in tumor bed delineation
for post-BCS EB APBI is the increasing utilization of oncoplastic
reconstructions at the time of BCS to achieve better cosmetic
outcome, during which the position of the tumor bed may be
shifted due to breast tissue rearrangement, the surgical cavity
may not represent the original tumor volumes. A recent retro-
spective study showed that in a cohort of 25 patients who
underwent oncoplastic reconstruction with a minimum of four
surgical clips placed at the time of BCS, 73% of patients had a
ﬁnal tumor bed extending beyond the original breast quadrant
where the tumor was located or was completely relocated to a
different region [30]. Identifying the tumor bed for EB APBI after
oncoplastic surgical remodeling can be difﬁcult, and the dis-
placement of the tumor bed can lead to a larger treated volume
due to the segmentation of the TBV into different locations in
the breast [31]. Whether certain surgical technique should be
184 Variability in breast tumor-bed delineationconsidered as one of the exclusion criteria for EB APBI is an area
of debate and requires more evidence.Methods for improving delineation consistency
Different approaches in improving delineation uniformity have
been tested and used by various groups. Overall, these studies can
be separated into four categories: utilization of standardized
guidelines, surgical clips and/or ﬁducial markers, pre-operative
CT scans, and additional imaging modalities in treatment planning.
Many investigators used more than one of the above techniques in
their studies. The results and limitations of each method are dis-
cussed in this section.Table 2
Studies showing utility of surgical clips in target localization.
Number
of
patients
Radiotherapy plan Results
Krawczyk
et al.
[38]
25 Tangential ﬁelds
planned with and
without clips visible
Surgical clips prevent
underdosing of the
lumpectomy cavity,
especially if it is on the
medial/lateral border of
breast tissue
Kovner
et al.
[37]
40 Boost of the
lumpectomy cavity
using surgical scar
vs. clips
1/4 of the lumpectomy
cavity was missed without
clips; clips also reduced the
total target volume
Benda
et al.
[35]
30 Boost of the
lumpectomy cavity
using surgical scar
vs. clips
Signiﬁcant underdosing of
the lumpectomy cavity
without clips: 49% of
patients received <90% of
prescribed doseStandardized guidelines
Given that the ability to identify the surgical cavity after breast-
conserving surgery (BCS) may vary depending on the experience of
the radiation oncologist, investigators have tested the impact of
implementing standardized guidelines on consistency in lumpec-
tomycavity contouring.Oneof theﬁrst studiesusingan institutional
protocol in contouring in breast cancer took place at the British
ColumbiaCancerAgency [17]. Basedonprior studies inpatientswith
bladder cancer and prostate cancer [32,33], the authors tested the
hypothesis that using precise contouring protocols would reduce
delineation variability. Eight radiation oncologists were asked to
contour the post-operative seroma on the treatment planning CT
scansofﬁvepatients. Theobserverswere separated into twogroups:
one group contoured with guidelines (the ‘‘trained’’ observers) and
the other group did not (the ‘‘untrained’’ observers). The guidelines
deﬁned the seroma target volume as the surgical cavity after
removal of the primary tumor, specifying that breast tissue strand-
ing should not be included in this volume. The guidelines then spec-
iﬁed the CTV and PTV expansions, with the CTV deﬁned as the
seroma volume plus a 1 cm expansion that is then trimmed to
5 mm from the skin and breast–chest-wall interface. The PTV was
deﬁned as CTV plus a 1 cm expansion. The authors found the con-
tours of the seroma volume, CTV, and PTV of the ‘‘untrained’’ cohort
were consistently and statistically signiﬁcantly larger than the
‘‘trained’’ cohort. During the second phase of the study, all eight
observers were given guidelines for contouring on ﬁve new patients
and the differences in volumes between the observers were no
longer signiﬁcant, demonstrating improvement in consistency
among radiation oncologists in volume delineationwhen they were
asked to followspeciﬁcguidelines. This studywas limitedby the lack
of evaluation of spatial conformity, as only volumetric data was
tested.Nopatients in thestudyhadclipsplaced in thesurgical cavity.
More recently, van Mourik et al. of the Netherlands Cancer Insti-
tute reported the ﬁndings of their multi-institutional study com-
paring thirteen radiation oncologists’ breast target volume
delineations of eight patients [34]. The authors observed signiﬁ-
cant volumetric and spatial interobserver variation in CTV (mean
CI = 0.53; SD = 0.6 cm), even with the use of delineation guidelines,
and the presence of clips or seroma reduced interobserver varia-
tion. The guidelines used in this study asked the observers to delin-
eate the original tumor bed or excisional cavity. If there was no
visible seroma, the observers were asked to contour the original
tumor location using all available pre-operative information to
delineate the tumor bed. If there was a visible seroma, the observ-
ers contoured the excisional cavity to include the seroma and the
seroma wall. The CTV was deﬁned as a 1.5 cm expansion around
these contours and excluded skin, muscle, ribs, and lung. The
PTV was then created with a 0.5 cm expansion of the CTV. The
authors found delineation differences between observers in the
contoured volumes and the locations of the targets, showing thatinterobserver variation was partly caused by differences in radia-
tion oncologists’ opinions on what should be considered as the tar-
get volume even while using guidelines.
These studies suggest that the presence of standardized delin-
eation guidelines may reduce differences in target delineation
among radiation oncologists. However, considerable variation can
still exist. While standardized guidelines remove some ambiguity
in target interpretation, subjective determination of the location
of the post-surgical cavity nevertheless contributes to interob-
server variability. Additional strategies should thus be considered
to improve consistency.Surgical clips and ﬁducial markers
Many previous studies have advocated the use of surgical clips
in localizing the lumpectomy cavity and guiding coverage for boost
irradiation to the tumor bed as part of BCT [35–38] (Table 2
includes examples of studies demonstrating the utility of surgical
clips.). As reported by van Mourik et al., the presence of visual
landmarks, such as surgical clips, within the lumpectomy cavity
signiﬁcantly improved observer consistency in tumor bed delinea-
tion (in patients with surgical clips, lowest CI = 0.47; in patients
without surgical clips, lowest CI = 0.19) [34]. While the authors
also reported that post-surgical seromas could reduce observer dis-
crepancies in their study, seroma formation heavily depends on
surgical techniques and its volume has been shown to be dynamic
during RT [39]. Therefore, surgical clips are considered more reli-
able visual landmarks and have been tested as surrogates for sur-
gical cavities [40].
In 2010, Dzhugashvili et al. at the Institut Gustave Roussy inves-
tigated whether the placement of surgical clips facilitated radiation
oncologists in delineating the lumpectomy cavity in the setting of
APBI [27]. In this study, tworadiationoncologistsprospectively eval-
uated 100 patients who had undergone lumpectomy with four sur-
gical clips placed at the time of surgery within the lumpectomy
cavity at the upper, inner, outer, and lower surgical margins. The
physicians delineated threeCT slices of the cavity,with surgical clips
deﬁning the superior and inferior slices, and the CT slice of the mid-
dle of the cavity did not include a surgical clip. Each lumpectomy
cavitywas also graded using a CVS system initially proposed by Lan-
dis et al. [15]. A CVS of 1–2 represented a poorly deﬁned cavity, 3
indicated an intermediately deﬁned cavity, and 4–5 indicated a
well-deﬁned cavity. The authors found surgical clips signiﬁcantly
improved clinicians’ ability to visualize the lumpectomy cavity
(29% of patients without surgical clips and with CVS scoresP3 vs.
75% of patients with surgical clips and CVS scores betweenP3). In
another study, the authors investigatedwhether surgical clips could
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ity contours of four radiation oncologists (two experienced physi-
cians, two trainees) of 40 patients [41]. CTV in this study was
deﬁned as surgical clips plus remodeled breast tissues (mobilized
glandular tissues adjacent to the tumor bed after wide local exci-
sion). The authors found the CTV CI to be relatively low for both
the trainees and experts (0.48 and 0.53, respectively). When only
CT slices containing surgical clips were assessed, the CI improved
for both groups of radiation oncologists (0.55 for trainees and 0.65
for experts). The same improvementwas demonstratedwith COMd.
When the entire CTVwas evaluated, the COMd ranged from 0.26 cm
to 0.35 cm and improved when only CT slices containing surgical
clipswere evaluated (0.18–0.3 cm). The authors concluded that sur-
gical clips improved the accuracy of lumpectomy cavity delineation,
since the CI between observers was increased by 16% (from 49% to
65%).
A limitation of surgical clips is that they may not be easily iden-
tiﬁed on portal images. Because of this, gold ﬁducial markers have
been used because they have the advantage of better visibility,
which allows for tracking the lumpectomy cavity during RT
through image guidance [42]. Shaikh et al. recently investigated
whether gold ﬁducial markers would improve interobserver accu-
racy in surgical cavity delineation in the setting of APBI [43]. In the
study, twenty-two patients were enrolled and eleven of them
received four to six gold ﬁducial markers during lumpectomy.
The post-lumpectomy cavities, CTV, and PTV were contoured inde-
pendently by 3 radiation oncologists. Before deﬁning the tumor
bed, the physicians were required to give each tumor bed a CVS
according to guidelines established by Smitt et al. [28]. The authors
found that a physician’s ability to visualize the cavity signiﬁcantly
improved with ﬁducial markers (mean CVS = 2.5 without markers
vs. 3.6 with markers). Also signiﬁcantly improved, as compared
to patients without gold ﬁducial markers, were the mean CTV CI
(0.43 without markers vs. 0.70 with markers; p < 0.0001) and
COMd (0.56 cm vs. 0.24 cm; p < 0.001), indicating that physicians
were able to identify the lumpectomy cavity more consistently.
Although visual landmarks, such as surgical clips and gold ﬁdu-
cial markers, are able to improve consistency in lumpectomy cavity
delineation, their accuracy in representing theoriginal tumorsite is a
matter of debate. Yang et al. recently reported that surgical clips are
not always consistentwith the tumor bed’s edge and therefore, may
not accurately represent theoriginal tumor site. Theauthorsdemon-
strated that the seroma on CT scans can extend beyond clips by
0.5 cm [44]. Similar ﬁndings were reported by Goldberg et al. [45],
who found that the lumpectomy cavity on CT scans exceeded the
clips by 0.7 cmmedially. These results suggest that the standardiza-
tion of clip placement should be considered as an important part of
surgical protocol to ensure RT accuracy.
It is important to keep in mind that each surgical clip marks
only a single point within the surgical bed, requiring observers to
interpolate the border of the cavity, which can contribute to inac-
curacy in target delineation. In some cases, the clips may be placed
beyond of the edges of the tumor bed, as surgeons may manipulate
them into more structurally stable tissue. For gold seeds, the stan-
dard gold seed applicator buries the seed into the tissue, rather
than placing it at the immediate edge of the tissue. Furthermore,
surgical clips and ﬁducial markers may help deﬁne the border of
the excised tissue, but they do not give us any information on
the distance of the tumor from the border, as the location of the
tumor within the excised specimen varies among patients, leading
to variable margins [46].Pre-operative CT scan
The use of a pre-operative CT scan in the RT treatment position
matched with a post-operative treatment planning CT scan toguide clinicians in identifying lumpectomy cavities was ﬁrst
described by Kirova et al. [47] The pre-surgical CT scan was per-
formed 1 week prior to BCS with the administration of intravenous
contrast and the postsurgical CT scan was performed 4–5 weeks
after lumpectomy. Rigid image registration was then performed,
matching different types of anatomical structures. The primary
tumor was seen and delineated on the pre-operative CT scan (gross
tumor volume [GTV]), and a region including surgical clips and the
GTV was then contoured on the post-operative CT scan and was
deﬁned as the CTV. While the authors demonstrated the feasibility
of identifying post-lumpectomy treatment volumes after registra-
tion of the pre- and post-operative CT scans, the inﬂuence of the
pre-operative CT on delineation was not analyzed in this study.
More recently, the use of deformable registration of pre- and
post-operative CT scans has been shown to add value in deﬁning
the post-operative tumor bed, especially in the setting of oncoplas-
tic surgery, where the breast tissue can be remodeled extensively
[48].
In a multi-institutional study, Boersma et al. investigated
whether using contrast-enhanced pre-operative CT scanning in
combination with a standardized delineation protocol could
decrease interobserver variation in boost irradiation target vol-
umes. The CT images of 26 patients enrolled in the study were con-
toured by ﬁve radiation oncologists [49]. First, the observers
contoured the TBV and the CTV (1.5 cm expansion of TBV) on the
post-operative planning CT scan and then, they contoured the
tumor on the pre-operative CT scan (GTV). The observers were pre-
sented with anatomy-matched scans of the pre-operative CT show-
ing the GTV and the post-operative planning CT showing the TBV
and CTV. With pre-operative volume data, the observers were
asked to adjust the TBV and CTV delineations for each patient as
needed. The authors found that using pre-operative CT as part of
CTV delineation resulted in smaller mean boost-CTVs (a decrease
from 42 cc to 36 cc; p = 0.005) and a signiﬁcant but modest reduc-
tion of the COMd of the CTV delineations (from 1.1 cm to 1.0 cm;
p < 0.001), without signiﬁcant change in CI and SD. The authors
concluded that incorporating pre-operative CT scans in tumor
bed delineation, in addition to standardized guidelines, resulted
in a signiﬁcant reduction of interobserver variation. Interestingly,
the authors reported a low mean CI in the study (0.36), which
was attributed to ambiguity in standardized guidelines regarding
excision cavity delineation. As the CI is highly dependent on the
absolute volume, a low CI value could also be attributed to the
small volumes reported in the study.
Although the addition of pre-operative CT scans to standardized
guidelines in tumor bed delineation appears to further reduce
interobserver discrepancy, there are limitations to this method.
First, not all breast tumors can be reliably and easily identiﬁed
on the pre-operative CT scan. In the multi-institutional study cited
above, one observer had difﬁculty identifying the correct GTV on
three patients. Second, because of different surgical margins used,
the relationship between the tumor volume and TBV may vary.
Third, due to post-surgical breast changes, it can often be difﬁcult
to reliably match the pre- and post-operative CT scans through
rigid registration. While the pre-operative tumor information is a
good reference, it is still important to consider other techniques
in helping clinicians to dependably identify the post-operative
tumor bed to ensure that APBI is accurately delivered.Additional imaging modalities
As shown in several studies, interobserver variation in lumpec-
tomy cavity delineation on CT scan is heavily inﬂuenced by the
clarity of the surgical cavity [15,27], and visual landmarks within
the surgical bed improve delineation consistency [19,34]. For
patients with poor seroma clarity or dense breast parenchyma, it
186 Variability in breast tumor-bed delineationis particularly challenging to differentiate the tumor bed from nor-
mal breast tissue, given the lack of contrast seen on CT scans [16].
Several investigators have addressed the use of additional imaging
modalities, either in conjunction with CT or direct comparison
against CT for better deﬁning the lumpectomy cavity.
Magnetic resonance imaging (MRI), ultrasound (US), and posi-
tron emission tomography (PET) are means to provide images of
soft tissue deﬁnition and inﬂammatory changes around the surgi-
cal site, which would be useful in deﬁning the tumor bed. Using
deformable registration to guide observers in tumor bed deﬁnition
is an ongoing area of research.
MR Imaging
In 2008, Whipp et al. investigated the appearances of post-oper-
ative cavities in 100 women who underwent BCS using MRI and
found the cavities tend to be heterogeneous in signal, suggesting
the formation of granulation tissue and that the true boundary of
the surgical cavity may be outside the seroma–tissue interface.
Thus, they proposed that an MRI scan may be superior to a CT scan
in deﬁning the tumor bed [50]. To investigate whether the addition
of MRI to CT and surgical clips improves delineation, Kirby et al.
enrolled 30 patients with 6–12 titanium clips placed in the exci-
sion cavity at the time of BCS and who underwent CT followed
by MRI [51]. The lumpectomy cavity was ﬁrst delineated on the
CT scan and then, on the MRI at least 2 weeks later by a single
observer. The MRI- and CT-deﬁned TBVs were then fused using
regions of interest corresponding to the midpoint of each surgical
clip to create a single MRCT-deﬁned lumpectomy cavity. The CTV
was created by adding a 1.5 cm margin to the tumor bed. The
authors found a CI of 0.54 between CT and MRCT for the tumor
bed and 0.84 for the CTV, concluding that intra-observer variation
in tumor bed delineation was signiﬁcantly higher with the CT scan.
However, the resulting clinical target volumes were sufﬁciently in
concordance, as the expansion of the margin resulted in larger vol-
umes and an increase in CI. Given these ﬁndings, the authors did
not feel the addition of MRI to CT and surgical clips would be
needed in tumor bed delineation for APBI.
More recently, interobserver variability in delineating the
lumpectomy cavity using MRI and CT scans was evaluated by Gie-
zen et al. [52]. In their study, ﬁfteen patients underwent RT treat-
ment planning CT scans and immediately afterward, an MRI scan
was performed in the treatment position. Four observers (two radi-
ation oncologists and two radiologists) assessed the CVS according
to Smitt et al. [28] and delineated the lumpectomy cavity on each
scan. Two patients did not receive surgical clips at the time of BCS
and the rest of the patients had 4–6 clips placed within the tumor
bed. The authors found that MRI resulted in a signiﬁcantly lower CI
(0.32 for MRI vs. 0.52 for CT) and higher COMd (0.11 cm with MRI
vs. 0.04 cm with CT). They also found that MRI was inadequate in
tumor bed localization in the setting of low CVS as surgical clip vis-
ibility on MRI was too low. The authors concluded that MRI added
no further information to CT for patients with low CVS and while
MRI may provide more information for patients with high CVS, it
must be combined with CT/surgical clip data for optimal tumor
bed delineation.
Ultrasound Imaging
In 2000, Robinovitch et al. published one of the earliest studies
using 2-dimensional (2D) US in visualizing the lumpectomy cavity
[53]. The authors compared surgical bed dimensions determined
by US to that determined by the evaluation of plain ﬁlm of 5–6 sur-
gical clips and found measurements derived by US were signiﬁ-
cantly smaller than that derived of clips. The authors concluded
that US is highly inaccurate in identifying the lumpectomy cavity.
Conﬂicting results were found by Ringash et al., where the authors
reported that US localization in lumpectomy cavities was adequatein 65% of patients and that it could be used when surgical clips are
not available [54]. A major disadvantage of these studies was that
no 3D imaging was used in the visualization of the tumor bed. In
2007, Coles et al. conducted a direct comparison of tumor bed
delineation of 3D US co-registered with CT, 2D US and CT, surgical
clips and CT, and CT alone [55]. Conﬁrming previous ﬁndings, the
authors found US (both 2D and 3D) showed a smaller lumpectomy
cavity volume than surgical clips, possibly due to tissue changes at
the edge of the cavity. Clips could also be pushed into the breast
tissue, leading to an increased volume marked by clips. It was con-
cluded that US, compared with the use of surgical clips and CT for
localization, deﬁnes different volumes as post-surgical remodeling
occurs. Interobserver consistency in lumpectomy delineation using
US was evaluated at the British Columbia Cancer Agency [56]. After
BCS, twenty patients underwent 3D US and treatment planning CT,
and three radiation oncologists contoured the post-operative ser-
oma on each image set. The authors found that, compared to CT
alone, the addition of 3D US was associated with a higher CI in
40% of cases, especially in patients with low seroma clarity on CT
alone and extremely dense breast parenchyma. Use of 3D US
may be useful in improving interobserver variation in selected
patients. However, if surgical clips on CT scan are considered the
gold standard, US may underestimate the TBV, as demonstrated
above (Table 3 summarizes the two interobserver studies for US
and MRI).PET/CT Imaging
In 2008, Ford et al. at the Johns Hopkins University [57] ﬁrst
used this imaging technique for lumpectomy cavity deﬁnition.
Since [18F]-ﬂuorodeoxyglucose (FDG) uptake in PET/CT has been
shown to be high in areas with inﬂammatory cell response
[58,59], the authors hypothesized that the lumpectomy cavity,
due to surgery, would exhibit inﬂammation and therefore, result
in greater FDG uptake. Enrolled in their study were twelve patients
with a median time from surgery to PET/CT of 49 days. The lump-
ectomy cavity was contoured on the CT scan by a radiation oncol-
ogist and on the PET/CT scan by both a radiation oncologist and
nuclear medicine physician. The authors found the lumpectomy
cavity was visualized well on PET/CT, but the PET/CT volumes were
larger than the CT volumes in all patients (median ratio, 1.68). It is
unclear if the PET/CT contour is more representative of the actual
extent of the lumpectomy cavity or if it is due to peri-surgical
inﬂammation. The authors concluded that TBV would likely be
overestimated using PET/CT. However, to date, there is no study
evaluating interobserver variations using these imaging methods.Alternatives to post-lumpectomy radiation
In order to eliminate issues of inaccurate lumpectomy cavity
delineation and interobserver variability, trials with APBI using
pre-operative EBRT followed by BCS are currently recruiting at var-
ious institutions [60,61]. At a trial at the Netherlands Cancer Insti-
tute, patients with early-stage breast cancer ﬁrst undergo a 12-day
course of APBI and then, the lumpectomy 6 weeks later. The extent
of the primary tumor is identiﬁed on treatment planning imaging,
thus eliminating the question as to what extent of the post-surgical
cavity represents the primary tumor location. Although the accu-
racy of CT-deﬁned tumor volume compared to MRI or US requires
more investigation, a comparative study on 41 patients with early-
stage breast cancer by Nichols et al. showed that the PTV delin-
eated from pre-lumpectomy CT was consistently smaller than that
delineated from post-lumpectomy CT [62]. Furthermore, the type
of surgical closure technique can inﬂuence the post-operative
TBV. Therefore, using pre-lumpectomy PTV for EB APBI will lead
to smaller treatment volumes and possibly, improved long-term
Table 3
Interobserver studies using MRI and ultrasound imaging.
Imaging Paper Observers Number
of
patients
Measures of interobserver consistency Conclusions
MRI vs. CT Giezen
et al.
[52]
4 (2 radiation
oncologists, 2
radiologists)
15 Signiﬁcantly lower CI with MRI (0.32) vs. CT
(0.52); signiﬁcantly higher COMd with MRI
(0.11 cm) vs. CT (0.04 cm)
MRI is worse for interobserver delineation
consistency. It can provide additional
information for patients with high CVS but its
use must be combined with CT data
3D Ultrasound (US) vs. CT Berrang
et al.
[56]
3 (radiation
oncologists)
20 CI improved with the use of US compared to CT in
40% of patients; US seroma clarity not affected by
dense breast tissue or low seroma volume
3D US improves interobserver variation in
select patients with dense breast
parenchyma, small seromas, or poor CT
seroma clarity
Table 4
Standards employed in ongoing trials of external beam partial vs. whole breast irradiation.
Publications Imaging modality Tumor bed delineation Tumor bed to
CTV margin
(mm)
CTV to PTV
margin (mm)
NSABP B-39/RTOG 0413
[24]
3D-conformal external beam, mammosite balloon
catheter, and multi-catheter brachytherapy
CT ± tumor bed clips 15 10
Ontario clinical
oncology group [23]
Multiple static tangent ﬁelds CT + 6 pairs of titanium clips recommended. CT or
ultrasound alone, only if seroma is visible
15 10
Danish breast cancer co-
operative group [22]
3D-conformal external beam radiation therapy CT ± tumor bed clips 15 5–8
IRMA [71] 3D-conformal external beam radiation therapy CT + tumor bed 3–6 surgical clip 15 5
SHARE [72] 3D-conformal external beam radiation therapy CT + 5–6 tumor bed clips NA 15–20
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operative RT is that there is the potential to delay deﬁnitive surgi-
cal management and that radiation can cause tissue changes that
render surgery more difﬁcult. Although a novel approach can
potentially change the treatment of early-stage breast cancer, this
shift in paradigm needs to be validated with the long-term out-
come that has already been established for the current paradigm
of BCS followed by adjuvant radiation.
Palta et al. recently conducted a dosimetric study of single-
fraction pre-operative APBI by creating virtual plans for seventeen
patients with unifocal stage T1 breast cancer [60]. A contrast-
enhanced MRI was used for treatment planning with the preoper-
ative tumor deﬁned as the GTV. CTV was a 1.5 cm expansion
around the GTV, and PTV was created as a uniform 3 mm expan-
sion of CTV minus the ﬁrst 5 mm of the subcutaneous tissue. The
prescription dose to the PTV was 15 Gy. Compared to 27 postoper-
ative PBI patients, the V100% and V50% were approximately 4 folds
smaller in the pre-operative APBI. The authors conclude that, in
addition to accurate coverage of the target volume, signiﬁcant
normal breast tissue sparing was achieved. A prospective phase I
trial is ongoing to evaluate this technique.Future directions and recommendations
So far, four general strategies have been investigated in reduc-
ing interobserver discrepancies among radiation oncologists. These
approaches help to improve the consistency of tumor bed delinea-
tion, but each has its own limitations. A delineation guideline is
designed to be implemented by individual clinicians with their
own interpretation and judgment and therefore, the results can
be subjective. Surgical clips are often regarded as a clinical stan-
dard, but there are questions over their accuracy in deﬁning the
lumpectomy cavity, as clips only deﬁne a few points around the
cavity’s border, which is highly deformable, and require subjective
interpolation, resulting in delineation inaccuracies. Multimodal
imaging only detects tumor bed surrogates, such as the original
tumor in pre-operative CT, electromagnetic features of the tumorbed in MRI, seroma in the lumpectomy cavity in US, and inﬂamma-
tory tissue around the excision site in PET. These surrogates may
not necessarily represent the true tumor bed, and as a conse-
quence, the size of the TBV delineated from these images varies
with the imaging modalities [51,55,56,62,63].
The current standard in multiple ongoing trials use the
combination of standardized guidelines and surgical clips or
ﬁducial markers to improve an observer’s ability in delineation
and observers consistency [34]. At Memorial Sloan-Kettering
Cancer Center, we also adopt this strategy in tumor bed delin-
eation for APBI. However, these strategies do not necessarily
address the accuracy in tumor bed deﬁnition. While some
studies have correlated pathology to multimodal imaging
[63–65] and others have addressed inter-/intra-fractional TBV
variations [23,66–68], these studies mostly focus on tumor
bed margins required for EB APBI and have been conducted
with small patient series.
We see a need for a systemic, multidisciplinary investigation
involving radiology, surgery, pathology, radiation oncology, and
medical physics. First, it is important to ﬁnd out what is the most
appropriate pre-operative imaging modality in deﬁning the tumor
extended by pathologic correlation. A direct comparison of pre-
operative imaging to tumor involvement in the lumpectomy spec-
imen is required. Second, as we know surgical techniques can
heavily inﬂuence the shape and size of the lumpectomy cavity,
studies are required to better deﬁne the beneﬁt in the standardiza-
tion of surgical clip placement. Furthermore, as clips can be dis-
placed with the expansion and contraction of the surgical bed,
studies correlating intraoperative imaging and serial post-opera-
tive imaging may be valuable to better understand clip displace-
ment before treatment planning. Lastly, we see a need for further
investigations in deformable image registration to aid physicians
in better deﬁning the most appropriate treatment volume. It is cur-
rently a challenge to reliably utilize deformable image registration
techniques to register images of two different imaging modalities,
such as CT and MRI [68–70], possibly due to the lack of internal
landmarks in breast imaging to serve as anchor points for deform-
able registration. Additional work is required to produce dependable
188 Variability in breast tumor-bed delineationresults with deformable image registration for physicians to com-
pare pre-operative tumor volume with post-operative TBV and
treatment planning volume.Concluding remarks
As APBI continues to gain popularity, accurate deﬁnition of the
lumpectomy cavity is crucial. EB APBI is being investigated in mul-
tiple ongoing studies. As interobserver variability is indicative of
observers’ abilities to accurately deﬁne the treatment target vol-
umes, variation in tumor bed delineation can potentially inﬂuence
the results of the ongoing trials. Nevertheless, we recognize this is
also representative of the current clinical practice environment.
Using surgical clips placed in the lumpectomy cavity at the time
of BCS to guide tumor bed delineation on CT is the method of
choice in ongoing APBI studies [22–24] (Table 4 summarizes these
ongoing trials). Although a similar CTV margin is being used in the
ongoing trials (1.5 cm), the expansion of CTV to PTV varies (0.5–
1.5 cm) [65].
In addition to improving tumor bed delineation accuracy and
reproducibility, the optimal margin required for CTV and PTV for
EB APBI continues to be an area of active investigation. As stated
above, tumor is often eccentric in a lumpectomy specimen. Studies
correlating tumor bed and the original tumor location may help cli-
nicians better understand whether a concentric expansion of the
lumpectomy cavity is suitable in deﬁning the clinical target vol-
ume, and studies of various 2D and 3D image guidance techniques
for EB APBI delivery may provide further insight on the appropriate
margin needed for PTV to account for daily setup variations.
In summary, investigators have tested multiple methods in
reducing observer variability and improving delineation accuracy
when contouring the lumpectomy cavity for EB APBI. Using stan-
dardized guidelines coupled with CT/surgical clips remains the
current gold standard in limiting observers’ variability. Nonethe-
less, this approach may be insufﬁcient in speciﬁc patients, such
as those with a closed cavity [41]. In patients without closed cavity
and with seroma formation, the seroma could also induce errors, as
it may not represent the primary tumor bed but rather the surgical
excision cavity. Further investigations are needed to explore
approaches for speciﬁc patient populations, and the integration
of MRI or US in addition to CT/surgical clips may be beneﬁcial for
those with dense breast parenchyma or poorly visualized cavities.References
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